TNON Tenon Medical, Inc. Insider Trading

TNON CCO bought 101,167 shares (+73.2% holdings); stock at 52-week low; 2 other insiders also bought in past 14 days

Grawey Nathaniel A., Chief Commercial Officer of Tenon Medical, purchased 101,167 shares, expanding his holdings from 138,114 to 239,281 shares (+73.2%) on 2025-11-14. This acquisition occurred as the stock trades at $1.13, down 69.9% from its 52-week high of $3.75, and follows a 90-day decline of -22.6%. Critically, a cluster buy pattern is present: 2 other insiders also purchased within the past 14 days, indicating concurrent insider accumulation at depressed valuations. The company remains structurally challenged—it reported $1.2M in quarterly revenue against $-3.3M net income, with negative full-year profitability, though annual revenue growth of +11.9% shows operational trajectory. The coordinated buying by multiple insiders during a sharp drawdown warrants examination of whether the stock's decline has revealed contrarian value or whether execution challenges persist beneath the surface revenue growth."

CIO Wyatt D. Geist buys 19,455 shares of TNON as 2 other insiders also buy; stock down -69.9% from 52-week high amid negative earnings.

Chief Innovation Officer Wyatt D. Geist purchased 19,455 shares on 2025-11-14, increasing his holdings by 14.1%, while the stock trades at $1.13—down -69.9% from its 52-week high of $3.75 and down -8.9% over the past 30 days. A cluster pattern emerges with 2 other insiders also buying within the past 14 days, suggesting coordinated confidence at depressed levels. However, the company remains deeply unprofitable with net income of $-3,339,000.00 against quarterly revenue of $1,173,000.00, a market cap of only $9,724,486.20, and no path to profitability visible in the fundamentals. The multiple insider accumulations in a distressed stock warrant investor scrutiny of the company's turnaround prospects and whether insiders possess non-public information not yet reflected in the share price decline.

CEO Foster buys 19,455 shares; 3 insiders buying in 14 days signals conviction amid stock down 69.9% from 52-week high.

Foster Steven M, CEO and President, purchased 19,455 shares on 2025-11-14, expanding his holdings from 3,423 shares to 22,878 shares (+568.4%). This transaction is part of a cluster pattern: 2 other insiders also bought within the past 14 days. The timing is notable given the stock's significant pullback: the current price of $1.13 is -69.9% from the 52-week high of $3.75. Against this backdrop, the CEO's substantial accumulation—nearly 6× his prior shareholding—occurs while the company faces fundamental challenges: net income was $-3,339,000.00 over the latest full fiscal year despite revenue growth of +11.9% to $1,173,000.00 in the most recent quarter. The coordinated multi-insider buying pattern during a prolonged drawdown warrants close attention to whether this reflects reasoned conviction or reflects external factors not yet visible in public filings.